381 related articles for article (PubMed ID: 19488446)
1. pH-responsive controlled release of antitumour-active polyoxometalate from mesoporous silica materials.
Sun G; Chang Y; Li S; Li Q; Xu R; Gu J; Wang E
Dalton Trans; 2009 Jun; (23):4481-7. PubMed ID: 19488446
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
Yang YJ; Tao X; Hou Q; Chen JF
Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764
[TBL] [Abstract][Full Text] [Related]
3. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of vitamin B2 using mesoporous materials functionalized with amine-bearing gate-like scaffoldings.
Bernardos A; Aznar E; Coll C; Martínez-Mañez R; Barat JM; Marcos MD; Sancenón F; Benito A; Soto J
J Control Release; 2008 Nov; 131(3):181-9. PubMed ID: 18727946
[TBL] [Abstract][Full Text] [Related]
5. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of antimicrobial compounds in mesoporous silica film monolith.
Izquierdo-Barba I; Vallet-Regí M; Kupferschmidt N; Terasaki O; Schmidtchen A; Malmsten M
Biomaterials; 2009 Oct; 30(29):5729-36. PubMed ID: 19628277
[TBL] [Abstract][Full Text] [Related]
7. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
[TBL] [Abstract][Full Text] [Related]
8. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials.
Balas F; Manzano M; Horcajada P; Vallet-Regí M
J Am Chem Soc; 2006 Jun; 128(25):8116-7. PubMed ID: 16787058
[TBL] [Abstract][Full Text] [Related]
9. Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors.
García-Peñas A; Gómez-Ruiz S; Pérez-Quintanilla D; Paschke R; Sierra I; Prashar S; del Hierro I; Kaluđerović GN
J Inorg Biochem; 2012 Jan; 106(1):100-10. PubMed ID: 22112846
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs.
Tao Z; Toms B; Goodisman J; Asefa T
ACS Nano; 2010 Feb; 4(2):789-94. PubMed ID: 20131868
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica material TUD-1 as a drug delivery system.
Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
[TBL] [Abstract][Full Text] [Related]
12. Functionalized mesoporous silica materials for controlled drug delivery.
Yang P; Gai S; Lin J
Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous materials for drug delivery.
Vallet-Regí M; Balas F; Arcos D
Angew Chem Int Ed Engl; 2007; 46(40):7548-58. PubMed ID: 17854012
[TBL] [Abstract][Full Text] [Related]
16. New liposome-encapsulated-polyoxometalates: synthesis and antitumoral activity.
Wang X; Li F; Liu S; Pope MT
J Inorg Biochem; 2005 Feb; 99(2):452-7. PubMed ID: 15621277
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles.
Limnell T; Heikkilä T; Santos HA; Sistonen S; Hellstén S; Laaksonen T; Peltonen L; Kumar N; Murzin DY; Louhi-Kultanen M; Salonen J; Hirvonen J; Lehto VP
Int J Pharm; 2011 Sep; 416(1):242-51. PubMed ID: 21763766
[TBL] [Abstract][Full Text] [Related]
19. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.
Lai CY; Trewyn BG; Jeftinija DM; Jeftinija K; Xu S; Jeftinija S; Lin VS
J Am Chem Soc; 2003 Apr; 125(15):4451-9. PubMed ID: 12683815
[TBL] [Abstract][Full Text] [Related]
20. Light- and pH-responsive release of doxorubicin from a mesoporous silica-based nanocarrier.
Knežević NŽ; Trewyn BG; Lin VS
Chemistry; 2011 Mar; 17(12):3338-42. PubMed ID: 21337435
[No Abstract] [Full Text] [Related]
[Next] [New Search]